Overview
- The Audit Office, which meets Thursday at 10:30 with victims’ families, is setting the plan for audits of the national drug regulator.
- The plan, requested by Congress, covers a management review of ANMAT from January 2023 to August 2025 and a tech audit of its drug traceability from January 2024 to December 2025.
- A federal judge said the state lacked real‑time monitoring, ANMAT could not locate fentanyl ampoules, and it depended on the manufacturer to carry out the recall.
- Authorities have confirmed 111 deaths linked to the tainted doses, including 18 in La Plata, and 14 people are detained in the case, among them lab owner Ariel García Furfaro.
- Two of six fentanyl lots produced in December 2024 at Laboratorios Ramallo tested contaminated, including a batch of 154,530 ampoules from which Hospital Italiano de La Plata bought 10,000.